MoneyInvestor's Business Daily
AstraZeneca Pays $2 Billion To Get Into High-Profile Cancer Space
Summit Therapeutics stock catapulted Tuesday after AstraZeneca made a $2 billion investment in the smaller biotech. The post AstraZeneca Pays $2 Billion To Get Into High-Profile Cancer Space appeared first on Investor's Business Daily.
Join the argument
House rules →Comments load as you scroll.